Pulse Biosciences, Inc.
PLSE· Nasdaq
PLSEPulse Biosciences, Inc.
Filed Aug 10, 2020 · 10-Q · 41 days after period end · 0001625101-20-000041
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$11.33M | -$11.36M | -$9.16M | -$6.18M |
| EPS Diluted | -$0.53 | -$0.55 | -$0.54 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 10, 2020 · 41 d after period end
